InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: None

Wednesday, 09/26/2012 1:34:44 PM

Wednesday, September 26, 2012 1:34:44 PM

Post# of 345997
Found this FDA document which might shed some light on how these errors were discovered.
Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance
http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/GuidancesInformationSheetsandNotices/ucm219488.htm
page 63 (of 63). The first document listed


So I assume that in the process of compiling this document they found the errors and that triggered an audit to be
done by an independent organization. I assume the errors were discovered during this phase to wrap up everything
before talking to FDA about phase 3 trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News